Sorafenib 200 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 200 mg
Reference Brands: Nexavar (US & EU)
Category: Oncology Cancer Care
Sorafenib is an oral kinase inhibitor used to treat advanced liver cancer (HCC), renal cell carcinoma (RCC), and thyroid cancer. Available in 200 mg tablets under the brand Nexavar® in the US and EU, it blocks tumor cell growth and angiogenesis. Ideal for B2B pharma distributors.
Product Description:
Sorafenib is a targeted therapy used in the treatment of advanced liver cancer (HCC), renal cell carcinoma (RCC), and thyroid cancer. As an oral kinase inhibitor, it works by blocking tumor cell proliferation and angiogenesis. Available under the brand name Nexavar®, it is marketed in 200 mg tablets in both the US and EU. Sorafenib is a critical component in the treatment of various solid tumors and is manufactured under GMP-compliant standards. Ideal for B2B pharmaceutical partners, it is supplied globally for oncology distributors and hospital tender markets seeking reliable oncology treatments.
Sorafenib — third party manufacturing & bulk supply
Sorafenib 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Sorafenib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Sorafenib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Sorafenib tosylate is used for the treatment of certain types of cancer, including hepatocellular carcinoma (liver cancer), advanced renal cell carcinoma (kidney cancer), and radioactive iodine-refractory differentiated thyroid carcinoma. It works by slowing tumor cell growth and reducing tumor blood vessel formation.
Sorafenib is made from the active pharmaceutical ingredient sorafenib tosylate, a multikinase inhibitor that blocks tumor cell proliferation and angiogenesis by targeting multiple intracellular and cell surface kinases.
The main international trade name is Nexavar.
The original branded product Nexavar is developed and marketed by Bayer. Generic sorafenib products are manufactured by multiple pharmaceutical companies worldwide after patent expiry in several regions.
The complete generic name is sorafenib tosylate.
The primary brand name is Nexavar.
Sorafenib tablets are manufactured in multiple countries including the USA, EU, UK, and India by Bayer and various GMP-certified generic manufacturers for global oncology supply.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
